Astec LifeSciences Ltd announced significant board and senior management changes on Monday, April 13, 2026, including the retirement of Nadir Godrej as chairperson and director with effect from close of business hours on April 13, 2026. According to reports from CNBC TV18, the company received his letter of willingness to retire and step down from the board. In a key leadership change, the board approved the appointment of Vishal Sharma as additional director (non-executive, non-independent) with effect from April 13, 2026, subject to shareholder approval, and designated him as chairperson of the board from the same date.
As reported by CNBC TV18, Sharma currently serves as executive director and chief executive officer (chemicals) at Godrej Industries Limited, the ultimate holding company. He brings approximately 30 years of experience in specialty and process chemicals across industrial and institutional segments, with his career spanning roles across Asia Pacific, India, the Middle East, and Africa. The board also noted the resignation of Burjis N. Godrej from the position of managing director with immediate effect, expressing his intention to focus on deeper involvement in Godrej Agrovet Limited, the parent company.
According to the company filing reported by CNBC TV18, the board approved the designation of Mathew Eipe as additional, non-executive, independent director for a term from April 13, 2026, to June 6, 2027, subject to shareholder approval. Eipe is an independent director at Godrej Industries Ltd and has held multiple senior leadership roles within the group. The board also approved the appointment of Arijit Mukherjee as additional director and executive director, designated as executive director & chief operating officer, for a three-year term from April 13, 2026, to April 12, 2029.
As reported by CNBC TV18, shares of Astec LifeSciences Limited ended at ₹634, down by ₹25.70, or 3.90%, on the BSE on April 13, 2026. Following these changes, the board composition will comprise 10 directors, including five independent directors and five non-independent directors. The company noted that not all appointees are debarred from holding office as directors under SEBI or other regulatory orders.
According to the company announcement reported by CNBC TV18, the 40th annual general meeting of the company will be held on July 20, 2026. The record date for the AGM and dividend payment has been fixed as July 3, 2026. The dividend, if approved at the AGM, will be paid or dispatched after July 20, 2026, within the stipulated timelines.
